WallStreetZenWallStreetZen

NASDAQ: KPTI
Karyopharm Therapeutics Inc Earnings & Revenue

KPTI past revenue growth

How has KPTI's revenue growth performed historically?
Company
-41.6%
Industry
182.01%
Market
17.81%
KPTI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KPTI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KPTI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

KPTI earnings and revenue history

Current Revenue
$145.9M
Current Earnings
-$139.8M
Current Profit Margin
-95.8%

KPTI Return on Equity

Current Company
N/A
Current Industry
15.4%
Current Market
-8.4%

Be the first to know when KPTI announces earnings.

KPTI Return on Assets

Current Company
-44.7%
Current Industry
2.2%
KPTI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KPTI Return on Capital Employed

Current Company
-55.8%
Current Industry
17.7%
KPTI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KPTI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KPTI$145.87M-$115.44M-$139.77M+35.73%N/A
SGMTN/AN/AN/AN/AN/A
ADAG$22.67MN/A-$36.44M+259.86%N/A
IVA$23.45M-$77.99M-$85.19M+108.09%N/A
ORMP$2.02M-$16.12M-$15.34M-5.65%N/A

KPTI earnings dates

Next earnings date
Feb 29, 2024

Karyopharm Therapeutics Earnings & Revenue FAQ

What were KPTI's earnings last quarter?

On Invalid Date, Karyopharm Therapeutics (NASDAQ: KPTI) reported Q3 2023 earnings per share (EPS) of -$0.30, up 33.33% year over year. Total Karyopharm Therapeutics earnings for the quarter were -$34.51 million. In the same quarter last year, Karyopharm Therapeutics's earnings per share (EPS) was -$0.45.

If you're new to stock investing, here's how to buy Karyopharm Therapeutics stock.

What was KPTI's earnings growth in the past year?

As of Q1 2024, Karyopharm Therapeutics's earnings has grown year over year. Karyopharm Therapeutics's earnings in the past year totalled -$139.77 million.

What is KPTI's earnings date?

Karyopharm Therapeutics's earnings date is Invalid Date. Add KPTI to your watchlist to be reminded of KPTI's next earnings announcement.

What was KPTI's revenue last quarter?

On Invalid Date, Karyopharm Therapeutics (NASDAQ: KPTI) reported Q3 2023 revenue of $36.01 million up 0.38% year over year. In the same quarter last year, Karyopharm Therapeutics's revenue was $36.15 million.

What was KPTI's revenue growth in the past year?

As of Q1 2024, Karyopharm Therapeutics's revenue has grown -41.6% year over year. This is 223.61 percentage points lower than the US Biotechnology industry revenue growth rate of 182.01%. Karyopharm Therapeutics's revenue in the past year totalled $145.87 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.